TLRYNasdaqMedicinal Chemicals & Botanical ProductsUS GAAP · USD

Tilray Brands, Inc.

Tilray Brands, Inc. is a U.S.-based consumer products company built around cannabis, beverage alcohol, wellness foods, and related branded products. Its portfolio includes Canadian and international cannabis brands, U.S. craft beer and spirits brands, and hemp-based food products, with operations across North America, Europe, Australia, and Latin America.

Liikevaihto915milj. USD
+11,5 %v/v
Liikevoitto (EBIT)−63,0milj. USD
+97,2 %v/v
EBIT-marginaali−6,9%
+271,1 %-yks.v/v
Nettotulos−121milj. USD
+94,4 %v/v

Tilikausi 2026 · muutos edellisvuodesta

Kehitys 2021–2026

−3 000−2 000−1 00001 000milj. USD2021: 513 milj. USD2021: EBIT −132 milj. USD20212022: 628 milj. USD2022: EBIT −610 milj. USD20222023: 627 milj. USD2023: EBIT −1 370 milj. USD20232024: 789 milj. USD2024: EBIT −175 milj. USD20242025: 821 milj. USD2025: EBIT −2 283 milj. USD20252026: 915 milj. USD2026: EBIT −63 milj. USD2026915−63
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Cannabis45 %

Adult-use and medical cannabis flower, pre-rolls, vapes, edibles, capsules, and beverages.

Beverage Alcohol40 %

Craft beer, seltzers, ciders, non-alcoholic beverages, and spirits sold under multiple brands.

Wellness Foods10 %

Hemp-based food and nutrition products sold primarily through the Manitoba Harvest brand.

Other Brands and Services5 %

Brand-related activities, distribution, brewpubs, and other ancillary revenue streams.

Asiakkaat

Tilray sells to adult-use cannabis consumers, medical patients, beverage distributors, retailers, restaurants, bars, and food shoppers. Its customer base spans regulated cannabis channels in Canada and international medical markets, plus U.S. beverage alcohol channels that include off-premises retail and on-premises hospitality. The company also serves patients and governments through medical cannabis supply agreements and distributors in overseas markets.

Adult-use cannabis consumers

Buy branded cannabis products for recreational use, with brand, potency, and price positioning driving choice.

Medical cannabis patients

Buy standardized THC and CBD products for prescribed or physician-guided use, valuing quality and supply reliability.

Beer, seltzer, and spirits consumers

Buy craft beverages through retail and hospitality channels, often choosing local or premium brands.

Retail and distributor partners

Purchase beverage and cannabis products for resale, prioritizing brand pull, assortment, and supply continuity.

Hemp food shoppers

Buy hemp-based nutrition products for everyday food and wellness use, often through grocery and natural channels.

Strategia

Tilray’s strategy is to build a house of brands across cannabis, beverage, and wellness, using scale and distribution to broaden its consumer reach. It emphasizes product innovation, category management, and entry into new geographies while also managing costs and integrating acquired brands and facilities. The company’s portfolio approach is meant to reduce dependence on any single category and create cross-category brand strength.

Grow branded cannabis and beverage portfoliosKeskipitkä aikaväli

Brand strength and product differentiation support shelf space, loyalty, and repeat purchases.

Expand innovation and new product formatsKeskipitkä aikaväli

New SKUs and formats help defend share and reach new consumer occasions.

Integrate acquisitions and rationalize distributionLyhyt aikaväli

Integration and channel focus are needed to capture synergies and improve route-to-market efficiency.

Pursue international medical cannabis opportunitiesKeskipitkä aikaväli

Export markets diversify revenue and leverage EU-GMP capabilities.

Maantiede

Q1/2026

Tilray is headquartered in Leamington and New York and operates across Canada, the United States, Europe, Australia, and Latin America. Canada is central to its cannabis business, while the U.S. is important for beverage alcohol and hemp foods; Europe and Australia are tied mainly to medical cannabis supply and regulatory approvals. Its geographic mix creates exposure to different regulatory regimes, distribution systems, and consumer preferences.

EMEA51 %
USA25 %
Kanada23 %
Other countries (US filing)0,9 %

Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.

Riskit

Tilray faces regulatory and licensing risk because cannabis remains tightly controlled across jurisdictions and export/import permissions can delay growth. It also faces integration risk from acquisitions, intense competition in cannabis and beverage alcohol, and asset impairment risk if acquired brands or intangibles underperform. The company’s multi-country footprint adds exposure to changing rules, distribution constraints, and local market preferences.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Goodwill and intangible asset impairment1Cannabis regulatory and licensing dependence2Acquisition integration risk3Competition from legal and illicit cannabis4Distribution and facility concentration5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Goodwill and intangible asset impairmentVaikutus: KorkeaTodennäköisyys: Korkea

    Acquired brands and businesses may not sustain expected cash flows or valuations.

    Kohdistuu: Craft beer and branded consumer assets

  2. Cannabis regulatory and licensing dependenceVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Sales, production, and exports depend on approvals, renewals, and compliance across jurisdictions.

    KohdistuuCanadaEuropeAustraliaInternational medical markets
  3. Acquisition integration riskVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Recent craft beer acquisitions must be integrated into operations, distribution, and brand strategy.

    Kohdistuu: Beverage segment

  4. Competition from legal and illicit cannabisVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Price, product mix, and shelf space are contested in both adult-use and medical channels.

    Kohdistuu: Canada and international cannabis markets

  5. Distribution and facility concentrationVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Production sites, distributors, and route-to-market relationships are essential to service levels.

    Kohdistuu: U.S. beverage operations and cannabis production

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition

Product sales and advisory/service revenue are recognized when control transfers, affecting period timing.

Vaikutus: Can shift reported revenue between quarters

Inventory valuation

Cannabis and beverage inventories require estimates for obsolescence, yield, and realizable value.

Vaikutus: Can affect gross margin and write-downs

Goodwill and intangible asset impairment

Acquired brands and businesses must be tested if performance weakens or assumptions change.

Vaikutus: Can create large non-cash charges

Business combinations and purchase accounting

Acquisitions create fair value step-ups and amortization that affect reported operating results.

Vaikutus: Impacts COGS, amortization, and adjusted gross profit

Stock-based compensation and deferred tax allowances

These estimates depend on valuation assumptions and future taxable income expectations.

Vaikutus: Can materially affect earnings and tax expense

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 24.9.2026